NCT03362242View on ClinicalTrials.gov

Study of ARO-AAT in Normal Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

March 12, 2018

Primary Completion Date

October 23, 2018

Study Completion Date

March 21, 2020

Conditions
Alpha 1-Antitrypsin Deficiency
Interventions
DRUG

ARO-AAT Injection

Single or multiple doses of ARO-AAT by subcutaneous (sc) injections

OTHER

Sterile Normal Saline (0.9% NaCl)

Calculated volume to match active comparator

Trial Locations (1)

1010

Auckland Clinical Studies Limited, Grafton

Sponsors
All Listed Sponsors
lead

Arrowhead Pharmaceuticals

INDUSTRY